Co-Diagnostics Signs Exclusive Distribution Agreement with Partner in Mexico
Co-Diagnostics has entered into an exclusive distribution agreement with its partner in Mexico for the Co-Dx PCR point-of-care platform, including the PCR Pro instrument and associated test kits, advancing the company's strategy to expand its commercialization network and footprint in Latin America ahead of the platform's market launch, which remains subject to applicable regulatory review and authorization. The company has generated over $18M in revenue through sales of its Logix Smart PCR tests and clinical lab testing equipment since 2020 with this distribution partner. The previously existing partnership was also instrumental in driving adoption of the company's Logix Smart COVID-19 PCR test, which comprised more than 50% of all COVID-19 tests used across Mexico through 2021, according to publicly available data of COVID tests performed during that period.
